What pharmacologic and supportive measures should be given to a child with laryngitis?

Treatment of Pediatric Laryngitis

For a child with acute laryngitis (croup), give oral or intravenous dexamethasone (0.3-0.5 mg/kg) as first-line therapy, and add nebulized racemic epinephrine for moderate-to-severe cases with stridor or respiratory distress. 1, 2

Pharmacologic Management

Corticosteroids - Primary Treatment

• Dexamethasone is the cornerstone of treatment for acute pediatric laryngitis
• Dosing: 0.3-0.5 mg/kg given orally or IV for 1-3 days depending on severity 2
• Can be administered as a single dose in mild cases or continued for several days in more severe presentations
• Budesonide nebulization (1.0 mg) can be added but offers no significant advantage over systemic steroids alone 2
• Most children show symptomatic improvement within 12-24 hours of steroid administration 2

Nebulized Racemic Epinephrine - For Moderate-to-Severe Cases

• Use nebulized racemic epinephrine for children with significant stridor, inspiratory dyspnea, or respiratory distress 1, 3
• This has become standard practice, with adoption rates increasing from 3-17% in 1993 to 87-94% in 2023 1
• Provides rapid relief of laryngeal edema and airway obstruction
• Can be repeated every 30 minutes initially if needed, then every 12 hours 2
• Particularly effective in emergency settings 3

What NOT to Give

Do not routinely prescribe antibiotics - this is a strong recommendation against their use 4. The rationale:

• Acute laryngitis in children is viral (parainfluenza, rhinovirus, influenza, adenovirus) 4, 3
• Antibiotics show no effectiveness for acute viral laryngitis 4
• They expose children to unnecessary side effects (rash, diarrhea, vomiting) and contribute to antibiotic resistance 4
• Use of antibiotics has appropriately declined from historical practice 1

Avoid antihistamines - their use has declined substantially as evidence shows no benefit 1

Supportive Measures

Home Care for Mild Cases

• Most children with mild laryngitis (no stridor at rest, minimal respiratory distress) can be managed at home 3
• Typical age of occurrence is 6 months to 3 years 3
• Symptoms usually resolve within 7-10 days regardless of treatment 4

Monitoring and Escalation

• Watch for signs requiring emergency intervention:
  • Persistent stridor at rest
  • Significant inspiratory dyspnea with use of accessory muscles
  • Cyanosis or pallor
  • Agitation, altered consciousness
  • Inability to maintain adequate oxygenation

Risk Factors for Treatment Failure

Be aware that despite dexamethasone treatment, approximately 18-19% of children may still require intubation 5. Higher risk groups include:

• Female patients (4-fold increased risk) 5
• Children with comorbid pulmonary or systemic disorders (7-fold increased risk) 5
• Elevated neutrophil-to-lymphocyte ratio 5
• Elevated IgM levels 5

Critical Pitfall to Avoid

In children under 1 year of age presenting with laryngitis-like symptoms, consider structural or functional airway anomalies 3. Recurrent or atypical presentations warrant laryngoscopy to rule out underlying anatomic problems that may be unmasked by viral infections.

Treatment Algorithm

1. Assess severity (stridor, retractions, dyspnea, cyanosis)
2. Mild cases (no stridor at rest): Oral dexamethasone, home management
3. Moderate-to-severe cases (stridor at rest, respiratory distress):
   • Dexamethasone (oral or IV)
   • Nebulized racemic epinephrine
   • Oxygen support as needed
   • Hospital observation
4. Monitor for improvement at 30 min, 1h, 2h, 6h, 12h, and 24h 2
5. If deteriorating despite treatment: Prepare for possible intubation, especially in high-risk patients 5

The effectiveness rate with appropriate steroid therapy is approximately 92% 2, making this a highly successful treatment approach when applied correctly.